Lab Notes: The Lipid Panel and the Tests That Tell the Rest of the Story
Lab Notes is a series from Camel City Women's Wellness dedicated to helping you understand the labs we order, why we order them, and what the results actually tell us, and don't tell us, about your health. Because a number on a page without context is just a number.
"Your Cholesterol Is Fine" - Why That May Not Be the Whole Story
The standard lipid panel is one of the most ordered labs in medicine and one of the most incompletely explained. Most women leave their annual visit knowing their LDL is "acceptable" without ever understanding what that means, whether it is truly low enough for their individual risk, or what the panel is missing entirely.
The lipid panel should be the beginning of the cardiovascular conversation, not the end of it. Here is what each marker means and what we add to get the full picture.
The Standard Lipid Panel
Total Cholesterol is the sum of all cholesterol-carrying particles in the blood. It provides a broad overview but is largely meaningless in isolation.
LDL Cholesterol is the primary treatment target in cardiovascular risk management. Decades of evidence confirm that lower LDL means lower cardiovascular risk. The new 2026 ACC/AHA Dyslipidemia Guidelines published just in March 2026 set specific targets:
Less than 100 mg/dL for borderline to intermediate risk
Less than 70 mg/dL for high risk
Less than 55 mg/dL for very high risk (established cardiovascular disease)
Important caveat: standard LDL is calculated, not directly measured, and becomes unreliable when triglycerides are elevated. It also measures cholesterol cargo not the number of particles carrying it. That distinction matters, and it is why ApoB is so valuable (we will talk about this in a bit).
HDL Cholesterol is the so-called "good cholesterol" because of its role in removing cholesterol from arterial walls. Low HDL, below 50 mg/dL in women, is an independent cardiovascular risk factor. However, higher is not always better; very high HDL does not appear to be additionally protective, and trials attempting to raise HDL pharmacologically have not reduced cardiovascular events. This is so important, because I often hear “oh but my ‘good’ cholesterol is really good”. As we say in yoga, too good is no good.
Triglycerides are one of the most sensitive metabolic markers on the lipid panel. Elevated fasting triglycerides almost always reflect insulin resistance, refined carbohydrate excess, physical inactivity, or metabolic syndrome. The triglyceride-to-HDL ratio is a useful quick calculation, a ratio above 3.0 suggests small dense LDL particle predominance and insulin resistance even when LDL appears acceptable. For perimenopausal women, estrogen decline reduces triglyceride clearance, so levels often rise without any dietary change.
Optimal fasting triglycerides: below 100 mg/dL. Values above 150 mg/dL warrant attention; above 500 mg/dL carries pancreatitis risk.
Beyond the Standard Panel: The Two Tests That Change the Conversation
Apolipoprotein B (ApoB): Counting What Actually Causes Plaques
ApoB is a structural protein found on the surface of every atherogenic particle in the bloodstream: LDL, VLDL, IDL, and Lp(a). Because each particle carries exactly one ApoB molecule, measuring ApoB directly counts the total number of plaque-forming particles. This is fundamentally different from LDL cholesterol, which measures how much cholesterol those particles are carrying.
Why does this matter? LDL particle number and LDL cholesterol do not always move together. A woman can have an LDL of 105 mg/dL with a high number of small, dense, highly atherogenic particles, and an elevated ApoB that reveals the true risk. Conversely, someone with a higher LDL composed of fewer, larger particles may have a lower ApoB and lower actual cardiovascular risk than their LDL suggests. This discordance is especially common in women with insulin resistance, metabolic syndrome, or elevated triglycerides. I've started measuring ApoB with every lipid panel, because this distinction matters.
The 2026 ACC/AHA Dyslipidemia Guidelines explicitly recommend ApoB for risk refinement in these populations.
Optimal ApoB: below 80 mg/dL. High risk target: below 70 mg/dL.
Lipoprotein(a) aka Lp(a): The Genetic Wildcard
Lp(a) is a uniquely structured lipoprotein with an LDL-like core and an additional protein that makes it particularly dangerous. It promotes atherosclerosis, impairs clot breakdown, and accelerates plaque inflammation simultaneously. Unlike every other lipid marker, Lp(a) is almost entirely determined by genetics. Diet, exercise, and statins have minimal effect on it. You largely have the Lp(a) you were born with.
Approximately 1 in 5 people carries elevated Lp(a) making it one of the most common genetic cardiovascular risk factors in existence. Wow! Yet it is not included in the standard lipid panel. A woman with an Lp(a) of 200 nmol/L can have a completely normal cholesterol panel and be told her cardiovascular risk is low while carrying a genetic burden that meaningfully elevates her lifetime risk of heart attack, stroke, and aortic valve disease.
Lp(a) is especially relevant for women because it rises with estrogen decline at menopause compounding the cardiovascular risk acceleration of the hormonal transition. Research also suggests elevated Lp(a) confers greater relative risk in women than in men at equivalent levels.
The 2026 ACC/AHA Dyslipidemia Guidelines recommend Lp(a) be measured at least once in every adult's lifetime. We check it in every patient at baseline, because every woman deserves to know.
High risk threshold: above 125 nmol/L. Very high risk: above 175 nmol/L.
The Bottom Line
The standard lipid panel is a starting point, not a complete cardiovascular risk assessment. LDL tells us about cholesterol concentration; ApoB tells us about particle burden; Lp(a) tells us about genetic risk that nothing else captures. Together, they paint a picture that is far more accurate, and far more actionable, than total cholesterol and LDL alone.
Lab Notes is an educational series from Camel City Women's Wellness. These posts are for educational purposes only and are not a substitute for individualized clinical evaluation.
